Patient Count Query definition

Patient Count Query means a direct query of the Research Repositories of one or more GPC Parties for De-identified Information in the form of patient counts necessary for an Affiliate Investigator to generate a hypothesis and/or determine if a Proposed Research Project is feasible within the GPC.
Sample 1Sample 2Sample 3

Examples of Patient Count Query in a sentence

  • The External Institution will verify that the Affiliate Investigator is authorized to submit Patient Count Queries, Feasibility Queries, and Proposed Research Projects and has completed any and all human subjects research training, and/or received IRB approval, as may be necessary for the Patient Count Query, Proposed Feasibility Query or Proposed Research Project.

  • The term “Approve,” and all other tenses of the word, used alone or as a modifier to another defined term (e.g., “Approved Research Project”) indicates the approval of a Patient Count Query, a Feasibility Query, or Research Project by the requisite GPC Committee(s).

  • The Participant responsible for the Data Requestor will verify that such Data Requestor is a Qualified Faculty or authorized Affiliate Investigator, and has completed any and all human subjects research training, and/or received IRB approval, as may be necessary for the Patient Count Query, Proposed Feasibility Query or Proposed Research Project.

  • The Party and its Qualified Faculty and Affiliate Investigators will continue to be bound by the terms of any agreement(s) governing any ongoing Research Project(s) or possession of Aggregate Response(s) from a completed Patient Count Query, Feasibility Query, or Research Project.

  • The term “GPC Data” means any data within each GPC Parties’ Research Repository which may, as contemplated by this Agreement, be provided or is provided to an External Institution or Affiliate Investigator in response to a Patient Count Query, Feasibility Query, and/or Research Project.

  • The External Institution and its Affiliate Investigators will continue to be bound by the terms of any agreement(s) governing any ongoing Approved Research Project(s) or possession of Aggregate Response(s) from a completed Patient Count Query, Feasibility Query, or Approved Research Project.

  • The term “Request,” and all other tenses of the word, used alone or as a modifier to another defined term (e.g., ‘Requested Participant’) indicates the request by a Data Requestor in his or her Proposal to the GPC that a particular Participant provide its Information (in the form of either De-Identified Information or a Limited Data Set) for a Patient Count Query, Feasibility Query, or Research Project.

  • The term “Data Requestor” means the person submitting a Patient Count Query, Feasibility Query, or Research Project.

  • The term “Request,” and all other tenses of the word, used alone or as a modifier to another defined term (e.g., ‘Requested Participant’) indicates the request by a Data Requestor in his or her Proposal to the GPC that a particular Participant provide its Information (in the form of De-Identified Information, a Limited Data Set or Identifiable Data) for a Patient Count Query, Feasibility Query, or Research Project.

  • This new information-knowledge must then be available to entrepreneurs to create new products that can reach the market, both domestic and export.

Related to Patient Count Query

  • Patient counseling means the written and oral communication by the pharmacist

  • Relevant Country means, as determined by the Calculation Agent, each of:

  • Over-Riding Nomination Criteria means the criteria set out in clause 4.2.

  • Patent Counsel means the DOE Counsel for Intellectual Property assisting the DOE Contracting activity.

  • Contractor Selection of Leave Trees means crop and leave trees are unmarked and will be selected by the Contractor.

  • Drug test means a test designed to detect the illegal use of a controlled substance.

  • Step therapy protocol means a protocol or program that establishes the specific

  • Drug use test means a scientifically substantiated method to test for the presence of illegal or performance-enhancing drugs or the metabolites thereof in a person’s urine.

  • Patient day or "resident day" means a calendar day

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • Routine patient care costs means Covered Medical Expenses which are typically provided absent a clinical trial and not otherwise excluded under the Policy. Routine patient care costs do not include:

  • Selection Criteria means and includes all of the requirements, considerations,

  • Clinical Trial means a Phase I Clinical Trial, Phase II Clinical Trial or Phase III Clinical Trial, or any post-approval human clinical trial, as applicable.

  • Voice over internet protocol service means any service that:

  • COVID-19 test means a viral test for SARS-CoV-2 that is:

  • Nomination Criteria means the criteria made up of the Over-Riding Nomination Criteria andthe Specific Nomination Factors, and is also referred to as “this Criteria”.

  • DRS/Profile means the system for the uncertificated registration of ownership of securities pursuant to which ownership of ADSs is maintained on the books of the Depositary without the issuance of a physical certificate and transfer instructions may be given to allow for the automated transfer of ownership between the books of DTC and the Depositary. Ownership of ADSs held in DRS/Profile is evidenced by periodic statements issued by the Depositary to the Holders entitled thereto.

  • Lead Compound means any compound of lead other than galena which, when treated in the manner described below, yields to an aqueous solution of hydrochloric acid a quantity soluble lead compound exceeding, when calculated as lead monoxide, five percent of the dry weight of the portion taken analysis.

  • Phase 1 Clinical Trial means a Clinical Trial of a Product on sufficient numbers of normal volunteers and/or patients that is designed to establish that such Product is safe for its intended use and to support its continued testing in Phase 2 Clinical Trials. For purposes of this Agreement, ‘initiation’ of a Phase 1 Clinical Trial for a Product means the first dosing of such Product in a human subject in a Phase 1 Clinical Trial.

  • Non-Administrator Substance Use Disorder Treatment Facility means a Substance Use Disorder Treatment Facility that does not meet the definition of an Administrator Substance Use Disorder Treatment Facility.

  • Random selection basis means a mechanism for selection of employees that:

  • Host county means the county within the human service zone in which the human service zone administrative office is located and in which the human service zone team members are employed.

  • Host Country means, with respect to an Insured Person, the country or territory the Insured Person is visiting or in which the Insured Person is living, which is not the Insured Person’s Home Country.

  • Random selection process means a process by which currently income-eligible households are selected for placement in affordable housing units such that no preference is given to one applicant over another except for purposes of matching household income and size with an appropriately priced and sized affordable unit (e.g., by lottery).

  • Licensed Level means a) when referenced in the context of a Named User, the quantity of Metric for which each individual Named User category and type is licensed -and- b) when referenced in the context of a Package, the quantity of Metric for which each individual Package is licensed; and

  • Pivotal Clinical Trial means, with respect to a Licensed Product, (a) a phase 3 Clinical Trial or (b) any other clinical trial that is intended (as of the time the study is initiated) to obtain the results and data to support (without the need to conduct any additional clinical trial) the filing of an application for Regulatory Approval for such product.